Skip to content
Neuronet
Neuronet - The support action for EU research on neurodegeneration
  • ABOUT
        • Objectives
        • Glossary
        • Work Packages
        • Partners
        • Executive Committee
        • Task Forces
        • Working Groups
        • Scientific Coordination Board
  • EVENTS
        • 2021: Virtual event
        • 2020: Virtual Event
        • 2019: The Hague
        • Event Calendar
  • NEWS
        • Latest news
        • Neuronet newsletters
        • Neuronet in the Media
  • PROJECTS
        • Ongoing Projects
        • Completed Projects
        • Project Overview
        • Project Timescales
  • RESOURCES
        • Asset Map
        • Project Tools
        • Regulatory & HTA Decision Tool
        • Neuronet Tools
        • Neuronet Deliverables
        • Neuronet Presentations
        • Publications
        • Useful resources for young researchers
  • KNOWLEDGE BASE

Mobilise-D

Enabling monitoring of health status, disease progression & evaluation of interventions in real-world situations

19th November 2021
Mobilise-D - Logo Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement

Digital mobility assessment using wearable sensor systems has the potential to capture walking performance in

Mobilise-D links with Voice Global to promote global patient engagement

16th November 2021
Mobilise-D - Logo Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement

Mobilise-D is now using the Voice Global platform as part of their Patient and Public

Neuronet launches its social media campaign “Programme impact analysis – where we are and where we need to go”

16th November 20218th November 2021
IMI nd projects social media campaign

The Neuronet project is setting up an efficient platform to boost collaboration across research projects

Spotlight on early-career researchers: a Neuronet interview with Alison Keogh

25th October 2021
Alison Keogh - UCD - Mobilise-D Spotlight on early-career researchers: a Neuronet interview with Alison Keogh

In this spotlight on early-career researchers interview, we speak with Alison Keogh. Alison works as

Neuronet convenes 7th meeting of its Scientific Coordination Board

10th January 202222nd October 2021
SCB update

On 21 October, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened

Novartis job opportunity for analysis of wearable sensor data for Digital Mobility Outcomes

10th January 202214th September 2021
DigitalDataScientist_Novartis_job

Novartis is now looking for a Digital Data Scientist to join their group and participate

EMA Public Support for Mobilise-D: Follow-up

15th September 20217th July 2021
Mobilise-D EMA_LetterOfSupport-1600x800

In the first year of Mobilise-D, the project asked the European Medicines Agency (EMA) for

Neuronet Working Groups emphasise the importance of effective collaboration to overcome obstacles linked to patient privacy and data sharing

2nd July 202130th June 2021
Neuronet Working Group

As a coordination and support action, Neuronet has been designed to enhance the impact and

Communication representatives of neurodegeneration research projects exchange on best practices

3rd March 202219th May 2021
Innovative Medicines Initiative projects on neurodegeneration

On 7 May, representatives of 12 Innovative Medicines Initiative neurodegeneration research projects met virtually to

Mobilise-D and IDEA-FAST announce the creation of the Digital Health Catalyst

28th April 202130th March 2021
DigitalHealthCatalyst-800x535

Mobilise-D and IDEA-FAST are pleased to announce the creation of the Digital Health Catalyst (DHC).

Post navigation
Older posts
Newer posts
← Previous Page1 Page2 Page3 Page4 Next →

LATEST NEWS

  • Neuronet publishes Frontiers in Neurology article, analysing the structure, assets and collaborative networks in the IMI neurodegeneration portfolio

    9th November 2022
    The Innovative Medicines Initiative (IMI) was launched in 2008, with an initial budget of €8bn.Read More
  • Spotlight on Early-Career researchers a Neuronet interview with Ilja Saris

    5th September 2022
    In this Neuronet spotlight on early-career researcher interview, we speak with Ilja Saris who worksRead More
  • Spotlight on Communication experts: A Neuronet Blog with Cindy Birck

    29th August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More
  • Webinar series: Mobilise-D presents its four patient cohorts

    25th August 2022
    Mobilise-D starts the autumn webinar series presenting the needs, technologies, protocols and user perspectives forRead More
  • Spotlight on Communication experts: A Neuronet Blog with Yoanna de Geus

    23rd August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More

Neuronet

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 821513. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.

Any information on this website solely reflects the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

 

 

Innovative Medicines InitiativeEU Flag logoEuropean Federation of Pharmaceutical Industries and Associations logoParksinson's UK logo

Disclaimer
About IMI
Legal notice
Privacy policy

@ 2019 – IMI-NEURONET

© 2026 - IMI-NEURONET
We use cookies to offer you a better browsing experience and to analyze site traffic. Read about how we use cookies and how you can control them in our Cookie Policy. If you continue to use this site, you consent to our use of cookies. AcceptCookie policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT